<DOC>
	<DOCNO>NCT02271022</DOCNO>
	<brief_summary>The primary objective UPSTREAM Registry address data gap regard course NSTEMI ( Non-ST-Elevation Myocardial Infarction ) ED ( Emergency Department ) arrival diagnostic angiography detail , characterize follow ED peri-ED use advance OAP ( Oral Anti-Platelet ) agent . In addition explore ED treatment pattern success ischemic bleeding risk stratification prior definition coronary anatomy , data generate via UPSTREAM registry allow plausible attribution ischemic bleeding outcome pre-catheterization antiplatelet therapy management NSTEMI . This registry seek demonstrate contemporary use upstream ticagrelor associate economically-sound utilization hospital resource , smooth transition care outpatient , secondary prevention set first 30 day hospitalization . Finally , allow characterization patient selection factor process ticagrelor v alternative OAP agent , carry descriptive comparison discharge . Patients transfer UPSTREAM hospital eligible inclusion , time OAP agent administration diagnostic catheterization begin ED care first hospital .</brief_summary>
	<brief_title>Utilization Ticagrelor Upstream Setting Non-ST-Segment Elevation Myocardial Infarction ( UPSTREAM ) : An ED-Based Clinical Registry</brief_title>
	<detailed_description>This Phase IV , post-approval , multicenter , prospective , noninterventional study consecutive patient work diagnosis NSTEMI ( Non-ST-Elevation Myocardial Infarction ) treatment OAP ( Oral Anti-Platelet ) agent ( ticagrelor , clopidogrel , prasugrel ) either ED ( Emergency Department ) , case within timeframe emergency physicians consider `` upstream '' - i.e. , within first 72 hour ED arrival least 4 hour diagnostic angiography . This registry design address data gap regard course NSTEMI ED arrival diagnostic angiography detail , characterize follow ED peri-ED use advance OAP agent . Demographic , ischemic v bleed risk stratification [ calculate retrospectively GRACE ( Global Registry Acute Coronary Events ) , TIMI ( Thrombolysis Myocardial Infarction ) , PURSUIT ( Platelet glycoprotein IIb/IIIa Unstable angina : Receptor Suppression Using Integrilin ) score , CRUSADE ( Can Rapid risk stratification Unstable angina patient Suppress ADverse outcomes Early implementation ACC/AHA guideline ) Bleeding Score , respectively ] , OAP agent data ( include , discernible , rationale agent selection ) collect UPSTREAM patient , regardless OAP therapy , discharge . Risk factor , angiography result , intervention/s ( ) , post-catheterization care , discharge regimen , in-hospital outcome record . Patients treat upstream , in-hospital , discharge home ticagrelor , follow , telephone and/or chart review ( necessary element include chart accessible investigator ) , 30 ( +10 ) day post-discharge , evaluation data element collect include patient-reported compliance visit medication , patient-reported healthcare resource utilization , pertinent event complication . Patients treat upstream , in-hospital , discharge home different OAP therapy ( clopidogrel prasugrel ) follow beyond data collection complete hospital discharge . It expect relatively small number patient change therapy ticagrelor another OAP agent discharge prior 30 day post-discharge , though change query 30-day call/chart review .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patients ( â‰¥18 year age ) work diagnosis NSTEMI treatment OAP agent ( ticagrelor , clopidogrel , prasugrel ) either ED , case within timeframe emergency physicians consider `` upstream '' i.e. , within first 72 hour care least 4 hour diagnostic angiography . In addition , patient undergo diagnostic coronary angiography within 72 hour ED arrival eligible UPSTREAM . 1 . Life expectancy le 90 day opinion treat clinician ; 2 . Not undergoing diagnostic angiography within 72 hour ED arrival ; 3 . Refusal consent ; 4 . Unlikely comply followup telephone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ACS , Acute Coronary Syndromes</keyword>
	<keyword>NSTEMI</keyword>
	<keyword>MI , Myocardial Infarction</keyword>
</DOC>